Literature DB >> 8176257

Structural organization of the human tyrosinase gene and sequence analysis and characterization of its promoter region.

S Ponnazhagan1, L Hou, B S Kwon.   

Abstract

Tyrosinase is the principal enzyme in the biosynthesis of melanin. The expression of tyrosinase is tissue-specific and appears to be regulated by various hormonal and environmental factors. Elucidation of the genomic structure and molecular basis of control of tyrosinase gene expression will greatly enhance our understanding of the regulation of human pigmentation. To this end, we have isolated and performed restriction mapping of recombinant cosmid and lambda phage clones containing the human tyrosinase gene, sequenced a 2.2-kilobase (kb) region of its promoter, and determined the potential regions regulating the tyrosinase gene expression in transient-expression system. The human tyrosinase gene is comprised of five exons and four introns. Based on our restriction mapping studies, the gene spans a distance of over 65-kb on chromosome 11 (q14-->q21). We constructed a series of plasmids (pHTY-CAT) that contain 5' sequential deletions of the human tyrosinase 5' flanking sequence fused to the reporter gene, chloramphenicol acetyltransferase (CAT). The plasmids were used to locate promoter regions that are potential regulators of tyrosinase gene expression in a transient expression system using melanoma cell lines. In human melanoma cells, the plasmid construct with a -2020 base pair (bp) promoter yielded the highest CAT activity. When the deletions reached -1739 bp, the CAT activity was dramatically reduced, indicating that important enhancer elements for transcription control are present between -1739 and -2020 bp. Further deletions up to -550 bp also resulted in dramatic decreases of CAT activity. However, when the deletion included -550 bp of the 5' flanking sequence, there was 26 percent of the CAT activity compared to that of the -2020 bp promoter. Deletions beyond -550 bp also showed markedly decreased CAT activity. Based on our data, we suggest that human tyrosinase gene expression is governed by both tissue-specific and multiple regulatory elements.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8176257     DOI: 10.1111/1523-1747.ep12376924

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  8 in total

Review 1.  Oculocutaneous albinism.

Authors:  S Biswas; I C Lloyd
Journal:  Arch Dis Child       Date:  1999-06       Impact factor: 3.791

2.  DNA damage enhances melanogenesis.

Authors:  M S Eller; K Ostrom; B A Gilchrest
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

3.  Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene.

Authors:  K Yasumoto; K Yokoyama; K Shibata; Y Tomita; S Shibahara
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

4.  Immunophenotyping of melanomas for tyrosinase: implications for vaccine development.

Authors:  Y T Chen; E Stockert; S Tsang; K A Coplan; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

5.  Molecular analysis of common polymorphisms within the human Tyrosinase locus and genetic association with pigmentation traits.

Authors:  Kasturee Jagirdar; Darren J Smit; Stephen A Ainger; Katie J Lee; Darren L Brown; Brett Chapman; Zhen Zhen Zhao; Grant W Montgomery; Nicholas G Martin; Jennifer L Stow; David L Duffy; Richard A Sturm
Journal:  Pigment Cell Melanoma Res       Date:  2014-05-12       Impact factor: 4.693

6.  Detection of regional melanoma metastases by ultrasound B-scan, cytology or tyrosinase RT-PCR of fine-needle aspirates.

Authors:  C Voit; A Schoengen; M Schwürzer; L Weber; T Mayer; T M Proebstle
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

7.  Correlation of positive RT-PCR for tyrosinase in peripheral blood of malignant melanoma patients with clinical stage, survival and other risk factors.

Authors:  T M Proebstle; W Jiang; J Högel; U Keilholz; L Weber; C Voit
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

8.  Antioxidant, antityrosinase and antitumor activity comparison: the potential utilization of fibrous root part of Bletilla striata (Thunb.) Reichb.f.

Authors:  Fusheng Jiang; Weiping Li; Yanfen Huang; Yitao Chen; Bo Jin; Nipi Chen; Zhishan Ding; Xinghong Ding
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.